DAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL '24
October 09, 2024 08:00 ET
|
Daxor Corporation
Elite Cardiovascular Leaders Unite: Driving Innovation Through Shared Excellence Oak Ridge, TN, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume...
Daxor Corporation to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
October 08, 2024 08:00 ET
|
Daxor Corporation
Oak Ridge, TN, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh...
Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device
September 27, 2024 17:00 ET
|
Daxor Corporation
Company to Focus on 510(k) Approval Path, Accelerating Time-to-Market Oak Ridge, TN, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume...
Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024
September 19, 2024 08:00 ET
|
Daxor Corporation
Oak Ridge, TN, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces its participation in the Annual...
Newly Published Review Highlights the Pivotal Role of Daxor’s Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome Management
September 12, 2024 08:00 ET
|
Daxor Corporation
Review Published in the Prestigious Journal Cardiorenal Medicine Oak Ridge, TN, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume...
Daxor Corporation Receives $300K Matching Fund Award From Launch Tennessee
September 05, 2024 08:00 ET
|
Daxor Corporation
The SBIR Matching Fund Award Will Drive Our Innovation, Commercialization Efforts, and Job Creation Oak Ridge, TN, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global...
Leading Central Florida Hospital Implements Daxor’s BVA-100™ Blood Volume Diagnostic for Heart Failure Patient Care
September 04, 2024 08:30 ET
|
Daxor Corporation
1,000 Bed Comprehensive Medical Center Launches ezBVA Lab Program Oak Ridge, TN, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement...
Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter
September 03, 2024 16:05 ET
|
Daxor Corporation
Oak Ridge, TN, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today provides a mid-year corporate and financial update...
Daxor Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference
September 03, 2024 12:15 ET
|
Daxor Corporation
Oak Ridge, TN, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh...
Daxor Corporation Announces Launch of BVA Program at Mid-South Largest Integrated Network
August 29, 2024 08:00 ET
|
Daxor Corporation
Community Hospital Purchases BVA Analyzer With Focus on Improving Outpatient Heart Failure Care Oak Ridge, TN, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader...